LUNGHI, Paolo
 Distribuzione geografica
Continente #
NA - Nord America 4.389
EU - Europa 4.092
AS - Asia 2.113
Continente sconosciuto - Info sul continente non disponibili 16
AF - Africa 5
OC - Oceania 4
SA - Sud America 2
Totale 10.621
Nazione #
US - Stati Uniti d'America 4.279
CN - Cina 1.668
IE - Irlanda 887
FI - Finlandia 791
SE - Svezia 694
IT - Italia 563
DE - Germania 511
UA - Ucraina 460
TR - Turchia 304
CA - Canada 107
GB - Regno Unito 74
IN - India 58
SG - Singapore 51
FR - Francia 28
BE - Belgio 19
RO - Romania 18
EU - Europa 16
AT - Austria 15
IR - Iran 15
NL - Olanda 11
VN - Vietnam 10
DZ - Algeria 5
CH - Svizzera 4
CZ - Repubblica Ceca 4
HK - Hong Kong 4
ES - Italia 3
MX - Messico 3
NZ - Nuova Zelanda 3
DK - Danimarca 2
LU - Lussemburgo 2
MD - Moldavia 2
PK - Pakistan 2
AL - Albania 1
AU - Australia 1
BR - Brasile 1
CO - Colombia 1
HR - Croazia 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
PL - Polonia 1
Totale 10.621
Città #
Dublin 887
Jacksonville 721
Chandler 674
Beijing 408
Dearborn 394
Izmir 275
Nanjing 275
Ashburn 241
San Mateo 236
Ann Arbor 217
Princeton 203
Wilmington 149
Parma 124
Shenyang 110
Toronto 95
Kunming 84
Jinan 83
Nanchang 82
Helsinki 78
Hebei 74
Hefei 59
Shanghai 53
Boardman 52
Changsha 50
Jiaxing 50
Düsseldorf 49
Grafing 46
Woodbridge 45
Tianjin 44
Seattle 39
New York 32
Guangzhou 31
Des Moines 30
Kocaeli 29
Norwalk 28
Pune 28
Zhengzhou 28
Los Angeles 26
Hangzhou 24
Fremont 21
Leawood 21
Houston 20
Brussels 19
Bremen 18
Ningbo 18
Taizhou 18
Lanzhou 17
Augusta 16
Falls Church 16
Haikou 16
Milan 15
Fuzhou 14
Rome 13
Vienna 12
Redmond 11
Borås 10
Dong Ket 10
Trezzano Sul Naviglio 10
Auburn Hills 9
Modena 9
Monmouth Junction 9
Novara 9
Timisoara 9
Wuhan 9
Bologna 8
Piacenza 8
Rockville 8
Angri 7
Focsani 7
Mumbai 7
Redwood City 7
Reggio Nell'emilia 7
Torino 7
Ardabil 6
Arzano 6
Cambridge 6
Mountain View 6
New Delhi 6
Shaoxing 6
Verona 6
Zanjan 6
Chengdu 5
Chongqing 5
London 5
Mestre 5
Quzhou 5
Reggio Emilia 5
Dallas 4
Langhirano 4
Montréal 4
Padova 4
Pievepelago 4
Savignano Sul Rubicone 4
Siena 4
Taiyuan 4
Trieste 4
Andover 3
Brescia 3
Brno 3
Catania 3
Totale 6.694
Nome #
Functional interplay between NIK and c-Abl kinases limits response to Aurora inhibitors in multiple myeloma 196
Attività biologica del tiosemicarbazone del piridossale e dei suoi complessi di rame 135
The Pharmacological Blockade of Phosphodiesterase IV Potentiates the Anti-Tumor Effects of Arsenic Trioxide (ATO) in Acute Myelogenous Leukemia Cells through Multiple Signaling Pathways 117
L'attività della wortmannin inibitore della fosfatidilinositolo-3 chinasi su cellule di leucemia mieloide cronica in fase cronica 114
MEK-INHIBITORS/ARSENIC TRIOXIDE COMBINATION THERAPY AS A NOVEL TREATMENT OPTION FOR TYROSINE KINASE INHIBITORS-RESISTANT PH+-LEUKEMIA 109
Endocanalicular transendothelial crossing (ETC): A novel intravasation mode used by HEK-EBNA293-VEGF-D cells during the metastatic process in a xenograft model 98
Hypoxia and Hypoxia Inducible Factor (HIF)-1{alpha} in Multiple Myeloma: Effect on the Pro-Angiogenic Signature of Myeloma Cells and the Bone Marrow Microenvironment 97
Human myeloma cells produce angiopoietin-1 but not angiopoietin-2: potential relationship with myeloma-induced angiogenesis 89
Hypoxia and hypoxia inducible factor (HIF)-1α in Multiple Myeloma patients: role in the angiogenic switch 89
L'inibizione della proliferazione indotta dal tiosemicarbazone della 2-piridina carbossialdeide e dai relativi complessi di stagno in linee cellulari umane e in cellule derivate da pazienti leucemici è associata ad apotosi 88
Alpha and Gamma interferons do not modulate the levels of JNK/SAPK activation in Ph+ leukemic cell lines 85
Alpha and gamma interferons do not modulate the levels of JNK/SAPK activation in PH+ leukemic cell lines 85
Fosforilazione in tirosina delle proteine adattatrici SHC ed attivazione di ERK-JNK/SAPK kinasi in leucemia acuta mieloblastica 85
Air purification and indoor biologic pollutants 81
Treatment with Arsenic Trioxide (ATO) and MEK1 inhibitor activates the p73-p53AIP1 apoptotic pathway in leukemia cells 78
Down-Modulation of Erk Protein Kinase Activity Inhibits Vascular Endothelial Growth Factor (VEGF) Secretion by human Myeloma Cell Lines 78
Alpha and gamma interferons do not modulate the levels of JNK/SAPK activation in PH+ leukemic cell lines 77
Transition-Metal Complexes of Isatin-beta-Thiosemicarbazone. X-Ray Crystal Structure of Two Nickel Complexes 76
Analisi dei meccanismi di attivazione di SHC, ERK e JNK in leucemia acuta mieloide 73
Pro-angiogenetic properties of human myeloma cells: production of angiopoietin-1 and its potential relationship with myeloma-induced angiogenesis 72
The ontogenesis of BCL2 oncogen protein in human hemopoietic development 72
2,6-Diacetylpyridine bis(thiosemicarbazones) zinc complexes: synthesis, structure, and biological activity 72
Activation of JNK/SAPK in acute myelogenous leukemia blast cells by anti-leukemic drugs 71
Pan-aurora kinase inhibitor MK-0457 synergistically potentiates Apo2l/TRAIL cytotoxicity in Multiple Mieloma cells sensitive and resistant to bortezomib 70
VASCULAR ENDOTHELIAL GROWTH FACTOR SECRETION BY MYELOMA CELLS IS INHIBITED BY DOWN-MODULATING ERK PROTEIN KINASE ACTIVITY 69
Acenaphthenequinone Thiosemicarbazone and Its Transition Metal Complexes: Synthesis, Structure, and Biological Activity 69
Attività biologica dei tiosemicarbazoni dell'acido alfa-chetoglutarico e della 2,6 diacetilpiridina 68
Activation of JNK/SAPK in acute myelogenous leukemia blast cells by anti-leukemic drugs 68
Early proinflammatory activation of renal tubular cells by normal and pathologic IgG 67
Analisi della chinasi ERK in leucemia acuta mieloblastica e malattie linfoproliferative croniche 65
Selective expression and constitutive phosphorylation of SHC proteins [corrected] in the CD34+ fraction of chronic myelogenous leukemias 64
High levels of ERK constitutive activity in acute myelogenous leukemia 64
Acenaphthenequinone thiosemicarbazone and its transition metal complexes: synthesis, structure, and biological activity. 64
Human myeloma cells production of angiopoietin-1 and its potential relationship with myeloma-induced angiogenesis 63
An abatement of the concentration of mycophytes, dust mites and pollens grains in the indoor environment using an air purifier 62
Tyrosine phosphorylation of SHC adaptor proteins in chronic myelogenous leukemia 62
Expression and activation of SHC/MAP kinase pathway in primary acute myeloid leukemia blasts. 62
BCL2 oncogene protein expression in human hematopoietic precursors during fetal life. 62
p29ING4 regulates the production of pro-angiogenic molecules by human myeloma cells in normoxic and hypoxic conditions being involved in myeloma-induced angiogenesis. 62
Downmodulation of ERK protein kinase activity inhibits VEGF secretion by human myeloma cells and myeloma-induced angiogenesis 61
Tyrosine-phosphorylation of SHC adaptor proteins and activation of ERK-JNK/SAPK MAP kinases in acute myelogenous leukemia 61
Activation of SHC and ERK kinase pathways in acute myelogenous leukemia 61
Selective inhibition of MEK1 kinase downmodulates ERK activity and proliferation of acute myeloid leukemia blasts 60
Combined treatment with the MEK inhibitor PD0325901 and Arsenic Trioxide has potent anti-tumor activity in vivo against human multiple myeloma xenograft model. 60
Arsenic Trioxide (ATO) and MEK1 inhibition synergize to induce apoptosis in acute promyelocytic leukemia cells 60
Le IgG normali e quelle di soggetti con lupus eritematoso sistemico esercitano un effetto pro-infiammatorio precoce su cellule tubulari umane 59
Riduzione di allergeni indoor con purificatore d’aria 59
An abatement of the concentration of mycophytes, dust mites and pollen grains in the indoor environment using an air purifier 59
The new tumor suppressor gene inhibitor of growth family member 4 (ING4) regulates the production of pro-angiogenic molecules by myeloma cells and suppresses hypoxia inducible factor (HIF)-1{alpha} activity being involved in myeloma-induced angiogenesis. 59
Attività della proteina del segnale ERK nell'auto-mantenimento, proliferazione e differenziazione delle cellule staminali ematopoietiche umane pluripotenti 59
: Expression and activation of SHC/MAP kinase pathway in primary acute myeloid leukemia blasts 58
Monitoring of emerging pollen grains in the Parma’s area (Northern Italy) 58
Attivazione costitutiva di ERK in leucemia acuta mieloblastica 58
High levels of P52/p46 SHC tyrosine-phosphorylation in CD34+ acute myelogenous leukemia 58
Human myeloma cells production of angiopoietin-1 and its potential relationship with myeloma-induced angiogenesis 58
Arsenic Trioxide in hematological malignancies: the new discovery of an ancient drug. 58
Betulaceae, Corylaceae, Cupressaceae, Fagaceae and Salicaceae around Parma (Northern Italy): pollen calendars from 1995 to 1997, 57
MDM2 inhibition synergistically enhances cytotoxicity of MEK1 inhibitor and Arsenic Trioxide (ATO) in AML blasts that retain a functional p53 pathway 57
MEK-ERK pathway is expressed but not activated in high proliferating, self-renewing cord blood hematopoietic progenitors 57
Synthesis, spectroscopic characterization and biological properties of new natural aldehydes thiosemicarbazones 57
Down-modulation of ERK protein kinase activity suppresses human myeloma cell proliferation and myeloma-induced angiogenesis by VEGF inhibition 57
Riduzione della concentrazione di micofiti, pollini e allergeni della polvere in ambienti confinati 57
Aurora and IKK kinases cooperatively interact to protect multiple myeloma cells from Apo2L/TRAIL 57
Synthesis, characterisation, X-ray structure and biological activity of three new 5-formyluracil thiosemicarbazone complexes 57
Chimica, struttura ed attività biologica di sistemi metallo-legante solforato 57
Emerging MEK inhibitors 56
Ontogenesi dell'oncogene BCL2 in tessuti emopoietici fetali 56
Acenapthenequinone thiosemicarbazone and its transition metal complexes. Synthesis, structure and biological activity 56
Selective inhibition of MEK1 kinase down-modulates ERK activity and proliferation of acute myeloid leukemia blasts 56
Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia 56
The reduction of the concentration of dust mites, mycophytes, and pollens grains in the indoor environment by means of an air purifier 56
Blockade of Aurora kinases activity enhances APO2L/TRAIL sensitivity in multiple myeloma 55
Massive expansion and proliferation of human hematopoietic progenitors are uncoupled with sustained ERK activity 54
The reduction of the concentration of dust mites, mycophites and pollen grains in the indoor environment by means of an air purifier 54
Down-modulation of ERK protein kinase activity inhibits vascular endothelial growth factor (VEGF) secretion by human myeloma cell lines 54
Role of GSTP1-1 in mediating the effect of As2O3 in the Acute Promyelocytic Leukemia cell line NB4. 54
Riduzione della carica batterica aerodispersa mediante utilizzo di un purificatore d'aria in ambienti indoor 54
High levels of p52/p46 SHC tyrosine-phosphorylation in CD34+ acute myelogenous leukemia 53
Infezione HCV, crioglobulinemia mista e linfoma linfoplasmocitoide: una eziopatogenesi comune? 53
Synthesis, characterization, X-ray strucrure and biological activity of three new 5-formyluracil thiosemicarbazone complexes 53
High self-renewal of human primitive hematopoietic stem cells taken from cord blood is uncoupled from sustained ERK activity 52
Betulaceae, Corylaceae, Cupressaceae, Fagaceae and Salicaceae around Parma (Northern Italy): pollen calendars from 1995 to 1997 52
Analisi della chinasi ERK in leucemia acuta mieloblastica e malattie linfoproliferative croniche 52
Emerging Raf inhibitors 52
Synthesis, structure, spectroscopic properties and biological activity of mixed diorganotin(IV) complexes containing pyridine-2-carbaldehyde thiosemicarbazonato and diphenyldithiophosphinato ligands. 52
An abatment of the concentration of mycophytes and pollen grains in the indoor environment using an air purifier 52
Selective inhibition of MEK! Kinase downmodulates ERK activity and prolifaretion of acute myeloid leukemia blasts 52
Downmodulation of ERK activity inhibits the proliferation and induces the apoptosis of primary acute myelogenous leukemia blasts 52
Down.modulation of ERK protein kinase activity inhibits VEGF secretion by human myeloma cells 51
High levels of ERK constitutive activity in acute myelogenous leukemia 51
L'inibizione selettiva della chinasi ERK controlla la proliferazione dei blasti di leucemia mieloide acuta 51
SHC proteins phosphorylation in chronic myelogenous leukemia 51
Activation of SHC and ERK kinase pathways in acute myelogenous leukemia 51
Analisi dei meccansimi di attivazione di SHC, ERK e JNK in leucemia acuta mieloide 51
Espressione e fosforilazione della proteina SHC in cellule emopoietiche neoplastiche 51
Downmodulation of ERK kinase activity inhibit the proligeration of acute myeloid blasts 50
Synthesis, structure, spectroscopic properties and biological activity of mixed diorganotin(IV) complexes containing pyridine-2-carbaldehyde thiosemicarbazonato and diphenyldithiophosphinato ligands 50
Resistance of multiple myeloma cells to trail is overcome by blockade of aurora kinases 50
Ontogenesis of signalling proteins:SHC, ERK, JNK expression and phosphorylation during human heart developpement 50
Espressione dell'oncogene BCL2 in cellule emopoietiche fetali umane 50
Totale 6.540
Categoria #
all - tutte 34.371
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.371


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019393 0 0 0 0 0 0 0 0 0 0 341 52
2019/20202.702 433 408 113 45 214 272 355 64 199 314 89 196
2020/20211.289 9 112 119 6 218 35 105 14 333 53 253 32
2021/2022976 18 13 8 26 22 54 109 170 52 121 107 276
2022/20232.980 398 260 181 182 249 310 17 187 1.095 12 78 11
2023/2024799 76 94 32 31 108 222 85 50 26 72 3 0
Totale 10.693